Why Don’t We Have a Cure for Alzheimer’s...

In the newest show from the Freakonomics Radio Network, host Zachary Crockett explores the hidden side of the things around us. This week: One creature’s trash is another’s cash. (Or, how one man found profit in pee.) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com ... Show More

A sneak peek at Bapu's new book, Random Acts of Medicine, available now from Doubleday, and an announcement about the show. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. 

Couples get divorced for all kinds of reasons. Is having kids one of them? Bapu talks about research that investigates what happens to parents who unexpectedly have twins. Plus, an announcement about the future of the show. Hosted by Simplecast, an AdsWizz company. See pcm.adswiz ... Show More

Why is it so hard to find a cure for Alzheimer’s? A simple answer is that the brain and its disorders are complicated. But as today’s guest, Charles Piller, writes, there’s another, more sinister factor at play. His new book, 'Doctored,' traces an incredible, true story of fraud, ... Show More

<p>The human brain is mysterious and complicated. So much so, one might be tempted to argue that it only makes sense that we still don't have a cure for Alzheimer's disease, despite decades of research. But this isn't the whole story. We've partnered with Vox's <em>Unexplainable< ... Show More

For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure? For more, go to http://vox.com/unexplainable It’s a great place to sign up for our newsletter, view show ... Show More

Over 100,000 people die from Alzheimer's Disease in the United States alone. Doctors are feverishly working to try and understand the disease in hopes of finding a cure. But the human brain holds many mysteries, and the results so far haven't been promising. Learn more about your ... Show More

This week, the first of a new series on substance use and what you need to know about ICE - crystal meth. Does early diagnosis of ovarian cancer through screening make a difference to survival rates? And the search for an Alzheimer's disease treatment is as controversial as ever. ... Show More

Prof. Klaus Ebmeier is the Foundation Chair of Old Age Psychiatry. In this interview he gives his point of view on dementia, normal aging and why new treatments are not yet effective. He also explains why failure is the bread-and-butter of research and gives valuable advice to fu ... Show More

This past July, a bombshell report in Science magazine suggested that a key Alzheimer’s study might have contained manipulated evidence. What does this mean for over a decade's worth of research? And where does the field go from here? For more, go to http://vox.com/unexplainable ... Show More

Aduhelm, known generically as aducanumab, is the first drug to actually affect the underlying disease process associated with Alzheimer's. Yet sales have been limited, and the drug is reaching very few patients — at least so far. It's expensive, risky and likely doing little to i ... Show More

For the nearly 7 million Americans living with Alzheimer’s, progress on treatments has felt painfully slow and incremental at best…until now. Dr. Sanjay Gupta traveled the country meeting people who have slowed, prevented, and in some cases even reversed the spread of Alzheimer’s ... Show More